Video

Timed Sequential Therapy for Actinic Keratosis: Report From the Mount Sinai Winter Symposium

At the 19th Annual Mount Sinai Winter Symposium, Dr. Gary Goldenberg spoke about actinic keratosis (AK) and the importance of timed sequential therapy. He discusses the AK march to show how AK is precancerous. He addresses how timed sequential therapy treats the individual lesions as well as the field. He also suggests alternative treatments for patients who cannot afford topical medications for AK.


 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

VIDEO: Consider adding photodynamic therapy to your practice
MDedge Dermatology
Average person with atopic dermatitis has no increased risk of actinic keratosis or nonmelanoma skin cancer
MDedge Dermatology
For preventing AKs, 5-FU beats placebo for up to 3 years
MDedge Dermatology
Actinic Keratosis as a Marker of Field Cancerization in Excision Specimens of Cutaneous Malignancies
MDedge Dermatology
Adding calcipotriene to 5-FU dramatically reduced AKs
MDedge Dermatology
Expert shares photodynamic therapy pearls
MDedge Dermatology
Veterans’ keratinocyte carcinoma, actinic keratosis care cost $356 million in 2012
MDedge Dermatology
Cooling, occlusion, and antihistamines are among the options that optimize ALA-PDT results
MDedge Dermatology
Update on New Drugs in Dermatology
MDedge Dermatology
Tinea Capitis Caused by Trichophyton rubrum Mimicking Favus
MDedge Dermatology